Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart FailureTherapy and Intervention

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

JACC Cardiovasc Interv

Kobari Y, Maznyczka A, Khokhar AA, Sørensen LM, Lulic D, Bieliauskas G, Raja AA, Ersbøll MK, Rossing K, Gustafsson F, Køber L, Prendergast B, Fosbøl E, De Backer O

doi: 10.1016/j.jcin.2025.10.050

Heart Failure

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

J Am Coll Cardiol

Min KH, Go AS, Lee K, Parikh RV, Horiuchi KM, Ambrosy AP, Tan TC, Srikanth K, Hamilton SA, Svetlichnaya J, Solomon SD, Inciardi RM, Vardeny O, Vasti E, Sandhu AT, Ku IA, Adatya S, Bhatt AS

doi: 10.1016/j.jacc.2025.05.040

Heart Failure

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Circulation

Basile C, Lindberg F, Benson L, Guidetti F, Dahlström U, Piepoli MF, Mol P, Scorza R, Maggioni AP, Lund LH, Savarese G

doi: 10.1161/CIRCULATIONAHA.124.072855

Heart Failure

Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission

ESC Heart Fail

Möckel M, Pudasaini S, Feldmann K, Baberg HT, Levenson B, Malzahn J, Mansky T, Michels G, Günster C, Jeschke E

doi: 10.1002/ehf2.15280

Heart Failure

Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey

Eur J Heart Fail

Seferović PM, Polovina M, Krejči J, Merkely B, Tokmakova M, Huelssmann M, Miloradović V, Apostolović S, Srbinovska-Kostovska E, Radovanović S, Stojšić-Milosavljević A, Milovančev A, Zdravković M, Glavaš D, Preradović-Kovačević T, Goncalvesova E, Laufer-Perl M, Marković-Nikolić N, Kušljugić Z, Hudić-Dizdarević L, Gaita D, Kamzola G, Sepp R, Simić D, Ristić A, Ašanin M, Krljanac G, Otašević P, Stanisavljević D, Miličić D, Abdelhamid M, Savarese G, Central/Eastern Europe QCC Survey Young Investigators

doi: 10.1002/ejhf.70031

Heart Failure

Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

Eur J Heart Fail

Bozkurt B, Mullens W, Leclercq C, Russo AM, Savarese G, Böhm M, Hill L, Kinugawa K, Sato N, Abraham WT, Bayes-Genis A, Mebazaa A, Rosano GMC, Zieroth S, Linde C, Butler J

doi: 10.1002/ejhf.3641

Heart Failure

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Eur J Heart Fail

Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G

doi: 10.1002/ejhf.3719

Heart Failure

Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement

Clin Res Cardiol

Esteban-Fernández A, Gómez-Otero I, López-Fernández S, López-Vilella R, Pastor-Pérez F, Otero-García Ó, Rodríguez-Santamarta M, García-Vega D, Fluvià P, Donoso-Trenado V, Sánchez-Corral E, García-Pinilla JM, Bonilla-Palomas JL, López López A, González-Juanatey JR, Bonet LA

doi: 10.1007/s00392-025-02663-y

Related content

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission

Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey

Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement